Advertisement

Comparative Clinical Pathology

, Volume 16, Issue 4, pp 259–264 | Cite as

Oxidative stress and antioxidant enzyme activities in patients with Hashimoto’s thyroiditis

  • Julieta GerenovaEmail author
  • Veselina Gadjeva
Original Article

Abstract

We investigated the parameters of oxidative stress in 71 Hashimoto’s thyroiditis patients. They were divided into three sub-groups according to the thyroid function: group I—euthyroid subjects; group II—hypothyroid subjects; and group III—subjects treated with Levothyroxin. Thirty healthy subjects were studied as controls. The level of lipid peroxidation (malondialdehyde, MDA) in the plasma and the antioxidant defences such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX) activities in erythrocytes were measured. Concentrations of MDA and SOD activity were not different in sub-groups of patients and controls. CAT activity was significantly lower in group II in comparison with both controls (p = 0.01) and group III (p = 0.02) as well as in group I compared to the controls (p = 0.04). Activity of GPX in erythrocytes in hypothyroidism was significantly higher compared to controls (p = 0.02). GPX activity in both groups I and III tended to be lower in comparison with controls. Our results indicate a deficiency of cellular antioxidative defense in Hashimoto’s thyroiditis patients in all stages of disease. Accordingly, we suppose that the supplementation with antioxidants from an early stage of the disease, in addition to thyroid hormone replacement, may have a positive benefit in the treatment.

Keywords

Hashimoto’s thyroiditis Cellular antioxidative defense Antioxidants 

Abbreviations

CAT

catalase

FT4

free thyroxine

GPX

glutathione peroxidase

HDL-C

HDL-cholesterol

H2O2

hydrogen peroxide

LDL-C

LDL-cholesterol

LT4

Levothyroxin

MDA

malondialdehyde

ROS

reactive oxygen species

SOD

superoxide dismutase

TC

total cholesterol

TG

triglyceride

Tg Ab

anti-thyroglobulin antibodies

TPO Ab

anti-thyroid peroxidase antibodies

TSH

thyroid-stimulating hormone

References

  1. Aksoy DY, Kerimoglu U, Okur H, Canpinar H, Karaagauglu E, Yetgin S et al (2005) Effects of prophylactic thyroid hormone replacement in euthyroid Hashimoto’s thyroiditis. Endocr J 52:337–343PubMedCrossRefGoogle Scholar
  2. Alvarado C, Alvarez P, Jimenez L, De la Fuente M (2006) Oxidative stress in leukocytes from young prematurely aging mice is reversed by supplementation with biscuits rich in antioxidants. Dev Comp Immunol 30:1168–1180PubMedCrossRefGoogle Scholar
  3. Amino N, Hagan SR, Yamada N, Refetoff HS (1976) Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid disease. Clin Endocrinol 5:115–125Google Scholar
  4. Beers R, Sizer T (1952) Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133–138PubMedGoogle Scholar
  5. Björkman U, Ekholm R (1995) Hydrogen peroxide degradation and glutathione peroxidase activity in cultures of thyroid cells. Mol Cell Endocrinol 111:99–107PubMedCrossRefGoogle Scholar
  6. Cadet J, Delatour T, Douki T, Gasparutto D, Pouget JP, Ravanat JL et al (1999) Hydroxyl radicals and DNA base damage. Mutat Res 424:9–21PubMedGoogle Scholar
  7. Das K, Chainy GB (2001) Modulation of rat liver mitochondrial antioxidant defense system by thyroid hormone. Biochim Biophys Acta 27:1–13Google Scholar
  8. Davies TF, Amino N (1993) A new classification for human autoimmune thyroid disease. Thyroid 3:331–333PubMedCrossRefGoogle Scholar
  9. Dayan CM, Daniels GH (1996) Chronic autoimmune thyroiditis. N Engl J Med 335:99–107PubMedCrossRefGoogle Scholar
  10. Demelash A, Kalsson J-O, Nilsson M, Björkman US (2004) Selenium has a protective role in caspase-3-dependent apoptosis induced by H2O2 in primary cultured pig thyrocytes. Eur J Endocrinol 150:841–849PubMedCrossRefGoogle Scholar
  11. Duntas LH, Mantzou E, Koutras DA (2003) Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 148:389–393PubMedCrossRefGoogle Scholar
  12. Fayadat L, Niccoli-Sire P, Lanet J, Franc J-L (1999) Role of heme in intracellular trafficking of thyroperoxidase and involvement of H2O2 generated at the apical surface of thyroid cells in autocatalytic covalent heme binding. J Biol Chem 274:10533–10558PubMedCrossRefGoogle Scholar
  13. Gamaley IA, Klyubin IV (1999) Roles of reactive oxygen species: signaling and regulation of cellular functions. Intern Rev Cytol 188:203–255Google Scholar
  14. Gärtner R, Gasnier BCH, Dietrich W, Krebs B, Angstwurm MWA (2002) Selenium supplementation in patients with autoimmune thyroiditis decrease thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 87:1687–1691PubMedCrossRefGoogle Scholar
  15. Gerenova J, Gadjeva V (2006) Influence of methimazole treatment on parameters of oxidative stress in patients with Graves’ disease. Comp Clin Pathol 15:49–54CrossRefGoogle Scholar
  16. Hammond LJ, Lowdell MW, Cerrano PG, Goode AW, Bottazzo GF, Mirakian R (1997) Analysis of apoptosis in relation to tissue destruction associated with Hashimoto’s autoimmune thyroiditis. J Pathol 182:138–144PubMedCrossRefGoogle Scholar
  17. Hampton MB, Orrenius S (1997) Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett 414:552–556PubMedCrossRefGoogle Scholar
  18. Hayashi N, Tamaki N, Konishi J et al (1986) Sonography of Hashimoto’s thyroiditis. J Clin Ultrasound 14:123–126PubMedCrossRefGoogle Scholar
  19. Howie AF, Arthur JR, Nicol F, Walker SW, Beech SG, Beckett GJ (1997) Identification of a 57-kilodalton selenoprotein in human thyrocytes as thioredoxin reductase and evidence that its expression is regulated through the calcium-phosphoinositol signaling. J Clin Endocrinol Metab 83:2052–2058CrossRefGoogle Scholar
  20. Komosinska-Vassev K, Olczyk K, Kucharz EJ, Marcisz C, Winsz-Szczotka K, Kotulska A (2000) Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves’ disease during therapy. Clin Chim Acta 300:107–117PubMedCrossRefGoogle Scholar
  21. Kotani T, Aratake Y, Hirai K, Fukazawa Y, Sato H, Ohtaki S (1995) Apoptosis in thyroid tissue from patients with Hashimoto’s thyroiditis. Autoimmunity 20:231–236PubMedGoogle Scholar
  22. Kraiem Z (1998) The measurement of antithyroid autoantibodies in the diagnosis and management of thyroid autoimmune disease. Clin Rev Allergy Immunol 16:219–225PubMedGoogle Scholar
  23. Mahoney JJ, Vreman HJ, Stevenson DK, Van Kessel AL (1993) Measurement of carboxyhemoglobin and total hemoglobin by five specialized spectrophotometers (CO-oximeters) in comparison with reference methods. Clin Chem 39:1693–1700PubMedGoogle Scholar
  24. Nunez J, Pommier J (1982) Formation of thyroid hormones. Vitam Horm 39:175–229PubMedCrossRefGoogle Scholar
  25. Okayasu I, Saegusa M, Fujiwara M, Hara Y, Rose NR (1995) Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma. J Cancer Res Clin Oncol 121:746–752PubMedCrossRefGoogle Scholar
  26. Oziol L, Faure P, Vergely C, Rochette L, Artur Y, Chomard P (2001) In vitro free radical scavenging capacity of thyroid hormones and structural analogues. J Endocrinol 170:197–206PubMedCrossRefGoogle Scholar
  27. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–170PubMedGoogle Scholar
  28. Plaser ZA, Cushman LL, Jonson BC (1966) Estimation of product of lipid peroxidation (Malonyl Dialdehyde) in biochemical systems. Anal Biochem 16:359–364CrossRefGoogle Scholar
  29. Resch U, Helsel G, Tatzber F, Sinzinger H (2002) Antioxidant status in thyroid disfunction. Clin Chem Lab Med 40:1132–1134PubMedCrossRefGoogle Scholar
  30. Rhee SG (1999) Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 31:53–59PubMedGoogle Scholar
  31. Riou C, Remy C, Rabilloud R, Rousset B, Fonlupt P (1998) H2O2 induces apoptoses of pig thyrocytes in culture. J Endocrinol 156:315–322PubMedCrossRefGoogle Scholar
  32. Sadani GR, Nadkarni GD (1996) Role of tissue antioxidant defense in thyroid cancers. Cancer Lett 109:231–235PubMedCrossRefGoogle Scholar
  33. Sugawara M, Kita T, Lee ED, Takamatsu J, Hagen JA, Kuma K et al (1998) Deficiency of thyroid superoxide dismutase in endemic goiter tissue. J Clin Endocrinol Metab 67:1156–1161CrossRefGoogle Scholar
  34. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMedGoogle Scholar
  35. Tanimoto C, Hirakawa S, Kawasaki H, Hayakawa N, Ota Z (1995) Apoptosis in thyroid diseases: a histochemical study. Endocr J 42:193–201PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2007

Authors and Affiliations

  1. 1.Section of Endocrinology, Department of Internal Medicine, Medical FacultyTrakia University HospitalStara ZagoraBulgaria
  2. 2.Department Chemistry and Biochemistry, Medical FacultyTrakia University HospitalStara ZagoraBulgaria

Personalised recommendations